15-22786671-TGCGGCA-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP3BP6BS2
The NM_144599.5(NIPA1):c.21_26del(p.Ala15_Ala16del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000835 in 1,065,976 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000047 ( 1 hom. )
Consequence
NIPA1
NM_144599.5 inframe_deletion
NM_144599.5 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.80
Genes affected
NIPA1 (HGNC:17043): (NIPA magnesium transporter 1) This gene encodes a magnesium transporter that associates with early endosomes and the cell surface in a variety of neuronal and epithelial cells. This protein may play a role in nervous system development and maintenance. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene have been associated with autosomal dominant spastic paraplegia 6. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_144599.5
BP6
Variant 15-22786671-TGCGGCA-T is Benign according to our data. Variant chr15-22786671-TGCGGCA-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 948284.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 45 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIPA1 | NM_144599.5 | c.21_26del | p.Ala15_Ala16del | inframe_deletion | 1/5 | ENST00000337435.9 | |
NIPA1 | NM_001142275.1 | c.-48+429_-48+434del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIPA1 | ENST00000337435.9 | c.21_26del | p.Ala15_Ala16del | inframe_deletion | 1/5 | 1 | NM_144599.5 | P1 | |
NIPA1 | ENST00000437912.6 | c.-48+12364_-48+12369del | intron_variant | 1 | |||||
NIPA1 | ENST00000561183.5 | c.-48+429_-48+434del | intron_variant | 1 | |||||
NIPA1 | ENST00000560069.5 | n.31+429_31+434del | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000324 AC: 45AN: 138958Hom.: 0 Cov.: 27
GnomAD3 genomes
AF:
AC:
45
AN:
138958
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000887 AC: 1AN: 11276Hom.: 0 AF XY: 0.000149 AC XY: 1AN XY: 6724
GnomAD3 exomes
AF:
AC:
1
AN:
11276
Hom.:
AF XY:
AC XY:
1
AN XY:
6724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000475 AC: 44AN: 926926Hom.: 1 AF XY: 0.0000406 AC XY: 18AN XY: 443670
GnomAD4 exome
AF:
AC:
44
AN:
926926
Hom.:
AF XY:
AC XY:
18
AN XY:
443670
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000324 AC: 45AN: 139050Hom.: 0 Cov.: 27 AF XY: 0.000326 AC XY: 22AN XY: 67480
GnomAD4 genome
AF:
AC:
45
AN:
139050
Hom.:
Cov.:
27
AF XY:
AC XY:
22
AN XY:
67480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This variant, c.21_26del, results in the deletion of 2 amino acid(s) of the NIPA1 protein (p.Ala15_Ala16del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with NIPA1-related conditions. This variant has been observed in at least one individual who was not affected with NIPA1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 948284). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Sep 01, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at